THY1 and liver cancer: Therefore, we first evaluated whether EpCAM-positive liver cancer cells would transform into CD90-positive liver cancer cells upon coculture with hepatic stellate cells (HSC) Lx2 and lung fibroblasts TIG3-20 to obtain a higher metastatic potential than CD90-positive liver cancer cells.